No paralogue variants have been mapped to residue 836 for SCN5A.
SCN5A | VLRSFRLLRVFKLAKSWPTLNTLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKNYS | 866 |
SCN1A | VLRSFRLLRVFKLAKSWPTLNMLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKSYK | 917 |
SCN2A | VLRSFRLLRVFKLAKSWPTLNMLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKSYK | 908 |
SCN3A | VLRSFRLLRVFKLAKSWPTLNMLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKSYK | 909 |
SCN4A | VLRSFRLLRVFKLAKSWPTLNMLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKSYK | 727 |
SCN7A | LLRLFRMLRIFKLGKYWPTFQILMWSLSNS>W<VALKDLVLLLFTFIFFSAAFGMKLFGKNYE | 654 |
SCN8A | VLRSFRLLRVFKLAKSWPTLNMLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKSYK | 902 |
SCN9A | VLRSFRLLRVFKLAKSWPTLNMLIKIIGNS>V<GALGNLTLVLAIIVFIFAVVGMQLFGKSYK | 882 |
SCN10A | VLRSFRLLRVFKLAKSWPTLNTLIKIIGNS>V<GALGNLTIILAIIVFVFALVGKQLLGENYR | 814 |
SCN11A | FLRSFRVLRVFKLAKSWPTLNTLIKIIGNS>V<GALGSLTVVLVIVIFIFSVVGMQLFGRSFN | 728 |
CACNA1A | VLRALRLLRIFKVTKYWASLRNLVVSLLNS>M<KSIISLLFLLFLFIVVFALLGMQLFGGQFN | 641 |
CACNA1B | VLRALRLLRIFKVTKYWSSLRNLVVSLLNS>M<KSIISLLFLLFLFIVVFALLGMQLFGGQFN | 637 |
CACNA1C | VLRCVRLLRIFKITRYWNSLSNLVASLLNS>V<RSIASLLLLLFLFIIIFSLLGMQLFGGKFN | 678 |
CACNA1D | VFRCVRLLRIFKVTRHWTSLSNLVASLLNS>M<KSIASLLLLLFLFIIIFSLLGMQLFGGKFN | 697 |
CACNA1E | VLRALRLLRIFKITKYWASLRNLVVSLMSS>M<KSIISLLFLLFLFIVVFALLGMQLFGGRFN | 630 |
CACNA1F | VLRCVRLLRIFKVTRHWASLSNLVASLLNS>M<KSIASLLLLLFLFIIIFSLLGMQLFGGKFN | 683 |
CACNA1G | VLRTFRLMRVLKLVRFLPALQRQLVVLMKT>M<DNVATFCMLLMLFIFIFSILGMHLFGCKFA | 892 |
CACNA1H | VLRTFRLLRVLKLVRFLPALRRQLVVLVKT>M<DNVATFCTLLMLFIFIFSILGMHLFGCKFS | 942 |
CACNA1I | VLRTFRLLRVLKLVRFMPALRRQLVVLMKT>M<DNVATFCMLLMLFIFIFSILGMHIFGCKFS | 789 |
CACNA1S | VLRCIRLLRIFKITKYWTSLSNLVASLLNS>I<RSIASLLLLLFLFIVIFALLGMQLFGGRYD | 586 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.V836M | c.2506G>A | Putative Benign | SIFT: Polyphen: |